vs
STANDARD BIOTOOLS INC.（LAB）与PodcastOne, Inc.（PODC）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是PodcastOne, Inc.的1.2倍（$19.6M vs $15.9M），PodcastOne, Inc.净利率更高（-1.0% vs -177.4%，领先176.4%），PodcastOne, Inc.同比增速更快（24.8% vs -11.5%），PodcastOne, Inc.自由现金流更多（$489.0K vs $-23.1M），过去两年PodcastOne, Inc.的营收复合增速更高（16.4% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
PodcastOne是一家知名音频娱乐企业，专注于播客制作、分发与变现业务，旗下拥有覆盖真实罪案、喜剧、新闻、体育、生活方式等品类的海量原创及授权播客内容，服务全球听众，同时为创作者和品牌提供广告解决方案。
LAB vs PODC — 直观对比
营收规模更大
LAB
是对方的1.2倍
$15.9M
营收增速更快
PODC
高出36.2%
-11.5%
净利率更高
PODC
高出176.4%
-177.4%
自由现金流更多
PODC
多$23.6M
$-23.1M
两年增速更快
PODC
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $15.9M |
| 净利润 | $-34.7M | $-154.0K |
| 毛利率 | 48.5% | 16.5% |
| 营业利润率 | -168.5% | -1.0% |
| 净利率 | -177.4% | -1.0% |
| 营收同比 | -11.5% | 24.8% |
| 净利润同比 | -28.8% | 90.3% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABPODC
| Q4 25 | — | $15.9M | ||
| Q3 25 | $19.6M | $15.2M | ||
| Q2 25 | $21.8M | $15.0M | ||
| Q1 25 | $40.8M | $14.1M | ||
| Q4 24 | — | $12.7M | ||
| Q3 24 | $22.1M | $12.2M | ||
| Q2 24 | $22.5M | $13.2M | ||
| Q1 24 | $45.5M | $11.7M |
净利润LABPODC
| Q4 25 | — | $-154.0K | ||
| Q3 25 | $-34.7M | $-975.0K | ||
| Q2 25 | $-33.5M | $-1.1M | ||
| Q1 25 | $-26.0M | $-1.8M | ||
| Q4 24 | — | $-1.6M | ||
| Q3 24 | $-26.9M | $-1.7M | ||
| Q2 24 | $-45.7M | $-1.4M | ||
| Q1 24 | $-32.2M | $-1.0M |
毛利率LABPODC
| Q4 25 | — | 16.5% | ||
| Q3 25 | 48.5% | 10.6% | ||
| Q2 25 | 48.8% | 9.6% | ||
| Q1 25 | 48.4% | 10.9% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | 54.9% | 8.3% | ||
| Q2 24 | 46.1% | 11.0% | ||
| Q1 24 | 53.1% | 8.9% |
营业利润率LABPODC
| Q4 25 | — | -1.0% | ||
| Q3 25 | -168.5% | -6.4% | ||
| Q2 25 | -118.1% | -7.0% | ||
| Q1 25 | -80.8% | -13.0% | ||
| Q4 24 | — | -12.4% | ||
| Q3 24 | -120.9% | -13.6% | ||
| Q2 24 | -134.5% | -10.4% | ||
| Q1 24 | -132.2% | -10.1% |
净利率LABPODC
| Q4 25 | — | -1.0% | ||
| Q3 25 | -177.4% | -6.4% | ||
| Q2 25 | -153.7% | -7.0% | ||
| Q1 25 | -63.8% | -13.1% | ||
| Q4 24 | — | -12.5% | ||
| Q3 24 | -122.0% | -13.7% | ||
| Q2 24 | -203.3% | -10.4% | ||
| Q1 24 | -70.6% | -9.0% |
每股收益（稀释后）LABPODC
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $3.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $15.8M |
| 总资产 | $539.6M | $24.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABPODC
| Q4 25 | — | $3.4M | ||
| Q3 25 | $129.4M | $2.7M | ||
| Q2 25 | $158.6M | $1.9M | ||
| Q1 25 | $150.9M | $1.1M | ||
| Q4 24 | — | $572.0K | ||
| Q3 24 | $210.6M | $1.4M | ||
| Q2 24 | $269.8M | $891.0K | ||
| Q1 24 | $287.1M | $1.4M |
总债务LABPODC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABPODC
| Q4 25 | — | $15.8M | ||
| Q3 25 | $399.7M | $14.7M | ||
| Q2 25 | $424.5M | $14.7M | ||
| Q1 25 | $454.6M | $15.1M | ||
| Q4 24 | — | $15.0M | ||
| Q3 24 | $489.3M | $15.5M | ||
| Q2 24 | $510.3M | $15.7M | ||
| Q1 24 | $577.3M | $16.3M |
总资产LABPODC
| Q4 25 | — | $24.7M | ||
| Q3 25 | $539.6M | $22.6M | ||
| Q2 25 | $557.0M | $22.3M | ||
| Q1 25 | $579.6M | $20.8M | ||
| Q4 24 | — | $20.6M | ||
| Q3 24 | $681.5M | $23.1M | ||
| Q2 24 | $708.7M | $24.0M | ||
| Q1 24 | $777.7M | $24.1M |
负债/权益比LABPODC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $579.0K |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $489.0K |
| 自由现金流率自由现金流/营收 | -118.1% | 3.1% |
| 资本支出强度资本支出/营收 | 4.5% | 0.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-111.1M | — |
8季度趋势，按日历期对齐
经营现金流LABPODC
| Q4 25 | — | $579.0K | ||
| Q3 25 | $-22.2M | $877.0K | ||
| Q2 25 | $-20.7M | $903.0K | ||
| Q1 25 | $-30.3M | $506.0K | ||
| Q4 24 | — | $-763.0K | ||
| Q3 24 | $-27.9M | $525.0K | ||
| Q2 24 | $-39.0M | $-480.0K | ||
| Q1 24 | $-62.5M | — |
自由现金流LABPODC
| Q4 25 | — | $489.0K | ||
| Q3 25 | $-23.1M | — | ||
| Q2 25 | $-22.6M | $791.0K | ||
| Q1 25 | $-35.3M | $505.0K | ||
| Q4 24 | — | $-783.0K | ||
| Q3 24 | $-30.1M | $464.0K | ||
| Q2 24 | $-41.0M | $-554.0K | ||
| Q1 24 | $-63.3M | — |
自由现金流率LABPODC
| Q4 25 | — | 3.1% | ||
| Q3 25 | -118.1% | — | ||
| Q2 25 | -103.6% | 5.3% | ||
| Q1 25 | -86.6% | 3.6% | ||
| Q4 24 | — | -6.2% | ||
| Q3 24 | -136.4% | 3.8% | ||
| Q2 24 | -182.2% | -4.2% | ||
| Q1 24 | -138.9% | — |
资本支出强度LABPODC
| Q4 25 | — | 0.6% | ||
| Q3 25 | 4.5% | 0.0% | ||
| Q2 25 | 8.7% | 0.7% | ||
| Q1 25 | 12.4% | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | 10.2% | 0.5% | ||
| Q2 24 | 8.6% | 0.6% | ||
| Q1 24 | 1.7% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
PODC
| Other | $9.0M | 56% |
| Barter | $6.9M | 44% |
